jpkrencn

事業内容

Cancer Xenograft Models

あなたはここにいる:ホーム > 事業内容 > Pharmacology > Cancer Xenograft Mod...

Medicilon has over 100 well-characterized Tumor Cell Line Xenograft models.  Our experienced staffs operate with strong theoretical basis.  We offer the services which are flexible for custom development of various types of models to meet the requirements of our clients.

Tumor Xenograft Models

Cancer Type Cell lines
Head and Neck KB, FaDu
Nasopharyngeal Carcinoma
Stem Cell
S18, S26
Lung Cancer DMS114, NCI-H69, NCl-H146, NCl-H209, NCI-H446, NCI-H526, NCI-H1688, 95-D, A549, Calu-1, Calu-3, Calu-6, HCC827, NCI-H226, NCI-H292, NCI-H358, NCI-H441, NCI-H460, NCI-H520, NCI-H522, NCI-H1299, NCI-H1437, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2009, NCI-H2122, NCI-H2126, NCI-H2228, PC-10, QG-56
Breast Cancer SUM159, MDA-MB-231, MDA-MB-468, Bcap-37, 2LMP, ZR-75-1, ZR-75-30
Gastric Cancer

MKN-45, NCI-N87, BGC-823, HGC-27, MKN-28, NUGC-3, SCH, SGC-7901, SNU-5, SNU-16, MGC-803

Pancreatic Cancer AsPC-1,BxPC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II,  MIAPaCa-2,  PANC-1
Renal Cancer ACHN, OS-RC-2, 786-O
Hepatocellular Carcinoma

Bel-7402, Hep-3B, Huh-7, PLC/PRF/5, QGY-7703, SK-HEP-1, SMMC-7721, HepG-2

Glioblastoma U87-MG
Colon and Cecum Cancer COLO 201, COLO 205, COLO 320 DM, CW-2, DLD-1, HCT-8, HCT-15, HCT-116, HCT116 P53 K0(-/-), HT-29, LoVo, LS1034, LS174T, LS411N, NCI-H716, RKO , SW48, SW620
Prostate Cancer 22Rv1, CL-1, DU145, LNCap Clone FGC, PC-3
Urinary Bladder HT-1197, HT-1376, RT4, SCaBER, SW780, T24
Ovary Cancer ES-2, HO-8910PM, PA-1, SK-OV-3, OVCAR-3
Endometrium/Hysterocarcinoma AN3 CA, HEC-1-A, ME-180, MFE-280
Skin Cancer Cell A431
Melanoma A375, B16, A2058, C32, HMCB, SK-MEL-30, MDA-MB-435s
Osteosarcoma Cell MG-63, SJSA-1
Sarcoma S-180
Muscle, Striated SJCRH30
Myeloma KMS-11, KMS-26, RPMI-8226
Leukemia / Lymphoma U937, THP-1, MV-4-11, HEL, TF-1a, ML-2, HL-60, L1210, K562, KARPAS-299, Daudi, Raji, Ramos, ARH-77, KMS-12-BM, KG-1

関連研究室